Alberta allowing self-referrals for privately paid MRI, CT and other imaging tests - CTV News

Nfld. & LabradorA joint government and health authority announcement on a new magnetic resonance imaging machine (MRI) coming to Grand Falls-Windsor, planned to be in service next year, has spurred concern and questions from technologists in the province. The health-care workers would like to be provided a human resources plan before further celebratory events, an advocate says. Wait times for urgent MRIs more than doubled last fiscal year, states NLHSAshley Fitzpatrick · CBC News · Posted: Oct 07, 2026 4:30 AM EDT | Last Updated: October 7Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. An MRI machine. (CBC)The announcement of a magnetic resonance imaging machine (MRI) coming to Grand Falls-Windsor came as announcements of multi-million dollar medical equipment always do in Newfoundland and Labrador, according to an advocate for MRI technologists in Atlantic Canada.

The Canadian Centre for Policy Alternatives joined Ontario Council of Hospital Unions of CUPE in pushing back against the privatization of health care during a media event in Sudbury Pushing back against the province’s privatization of health care, the Canadian Centre for Policy Alternatives has joined CUPE in a media tour of the province.

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.